FAMOTIDINE; IBUPROFEN | A211890 | ALKEM LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Horizon Medicines LLC v. Alkem Laboratories Ltd. 6 patentsANDA 211890Ibuprofen and Famotidine | D. Del. | 2018-07-09 | Terminated 2020-11-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.9449
per ea
Lowest NADAC/Unit
$0.9449
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 67877062690IBUPROFEN-FAMOTIDIN 800-26.6 MG | $0.9449 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.